Condition
Regurgitation, Aortic Valve
Total Trials
7
Recruiting
0
Active
0
Completed
5
Success Rate
71.4%-15% vs avg
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
Termination Rate
28.6%
2 terminated out of 7 trials
Success Rate
71.4%
-15.1% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
40%
2 of 5 completed with results
Key Signals
2 with results71% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (6)
Trial Status
Completed5
Terminated2
Trial Success Rate
71.4%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07573852Completed
ECG and CXR for Predicting Cardiovascular Diseases
NCT01700439Not ApplicableCompleted
Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve
NCT03578952Not ApplicableTerminated
Evaluation of Effectiveness and Safety of Evolut R Valve In Patients With Pure Aortic Regurgitation
NCT00475709Not ApplicableCompleted
Aortic Valve Replacement With Trifecta(TM)
NCT00475267Not ApplicableCompleted
Aortic Valve Replacement With Trifecta(TM)
NCT00727181Not ApplicableCompleted
An Observational, Prospective Evaluation of the Trifecta™ Valve
NCT01810679Not ApplicableTerminated
Perceval S Aortic Heart Valve Study- North America
Showing all 7 trials